Cynthia L. Feldmann - 08 Aug 2025 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Director
Issuer ticker: STE
Reported as of: 08 Aug 2025
Net transaction value: -$844,252
SEC form: 4
Accepted by SEC: 12 Aug 2025, 17:25:57 UTC
Prior SEC filing: 06 Jun 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Cynthia L. Feldmann filed Form 4 for STERIS plc (STE) on 12 Aug 2025.

Key facts

This page summarizes Cynthia L. Feldmann's Form 4 filing for STERIS plc (STE).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Aug 2025, 17:25.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: -$844,252.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001264554 Primary reporting owner

FELDMANN CYNTHIA L

Relationship: Director
Address: C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 12 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +3,495
Change %: +496%
Price: $0.000000
Shares after: 4,200
Date: 11 Aug 2025
Ownership: Direct

STE transaction

Ordinary Shares

Sale

Transaction value: $844,252
Shares: -3,495
Change %: -83%
Price: $241.56
Shares after: 705
Date: 11 Aug 2025
Ownership: Direct
Footnotes: F1

STE holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,663
Date: 08 Aug 2025
Ownership: See Footnote Below
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,407
Change %
Price: $0.000000
Shares after: 1,407
Date: 08 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,407
Exercise price: $242.85
Footnotes: F3

STE transaction Derivative

Career Restricted Stock Units

Award

Transaction value: $0
Shares: +487
Change %: +6.4%
Price: $0.000000
Shares after: 8,128
Date: 08 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 487
Exercise price
Footnotes: F4, F5

STE transaction Derivative

Director Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -3,495
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 11 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 3,495
Exercise price: $114.74
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Price reflects a weighted average sale price for multiple transactions ranging from $241.38 to $241.705 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

These ordinary shares are held in the Cynthia L. Feldmann Revocable Trust, with Ms. Feldmann and her husband as Trustees.

Footnote F3

These nonqualified stock options are fully vested and are exercisable immediately.

Footnote F4

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

Footnote F5

These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.